Stock Screener App

Gratuito -

Installare

20.91

3.62% 0.73

after-market

Dopo l'orario di chiusura: 20.91

Amphastar Pharmaceuticals Inc (AMPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AMPH Giù? Forum Previsione

Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie

Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 3.6% Rally? GF Value Says Undervalued - GuruFocus

Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals - simplywall.st

Amphastar Pharmaceuticals (AMPH) Director Richard Prins Sells 7, - GuruFocus

Richard Prins Sells 7,973 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat

Amphastar director Richard Prins disposes of shares valued at $161,851 By Investing.com - Investing.com South Africa

Amphastar director Richard Prins disposes of shares valued at $161,851 - Investing.com

Director Richard Prins sells 7,973 Amphastar (AMPH) shares at $20.30 - Stock Titan

Amphastar CFO William Peters sells $183,886 in company stock - Investing.com

Enterprise value to EBITDA forward of Amphastar Pharmaceuticals, Inc. – MUN:29A - TradingView

Amphastar Pharmaceuticals (NASDAQ:AMPH) CFO William Peters Sells 8,180 Shares - MarketBeat

Amphastar (AMPH) CFO exercises options and sells 8,180 shares in 10b5-1 trade - Stock Titan

AMPH (AMPH) schedules Rule 144 stock sale tied to RSU vesting - Stock Titan

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat

Weekly Recap: Amphastar Q2 growth, $100M BAQSIMI and IMS FDA warning - TradingView

Results: Amphastar Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - moomoo.com

Amphastar Pharmaceuticals (AMPH) Stock Rebound Meets Margin Pressure And Valuation Gap - Sahm

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Wall Street Zen to "Strong-Buy" Rating - MarketBeat

Amphastar Pharmaceuticals, Inc. SEC Filing (Aug 7, 2026) - Stock Titan

Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $20.00 by Analysts at Piper Sandler - marketbeat.com

Wells Fargo & Company Increases Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00 - MarketBeat

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up After Strong Earnings - MarketBeat

Amphastar Pharmaceuticals (NASDAQ:AMPH) Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS - MarketBeat

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Amphastar Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Amphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026 - Yahoo Finance

Amphastar Pharmaceuticals (NASDAQ: AMPH) Q2 revenue rises 5% with margin gains - Stock Titan

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 - Arizona Daily Star

Pacer Advisors Inc. Buys 83,739 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings - The Globe and Mail

Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Dimensional Fund Advisors LP - MarketBeat

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 8.80% Upside Potential - DirectorsTalk Interviews

Arrowstreet Capital Limited Partnership Has $6.37 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 - TradingView

Amphastar Pharmaceuticals Inc (AMPH) Cash Flow - TradingKey

Amphastar Pharmaceuticals Inc (AMPH) Institutional Confidence - TradingKey

Rice Hall James & Associates LLC Increases Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Amphastar Pharmaceuticals Inc (AMPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Amphastar Pharmaceuticals Inc (AMPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Amphastar Pharmaceuticals Inc (AMPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

TradingKey - TradingKey

AMPH|Amphastar Pharmaceuticals Inc|Price:19.180|Chg%:+0.460 - TradingKey

Amphastar Pharmaceuticals Inc - TradingKey

AMPH|Amphastar Pharmaceuticals Inc|Price:18.720|Chg%:-0.150 - TradingKey

Amphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Epoch Investment Partners Inc. - MarketBeat

Amphastar Pharmaceuticals Inc (AMPH) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada

Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks

Amphastar Pharmaceuticals Inc (AMPH) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Amphastar Pharmaceuticals Inc (AMPH) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history - Yahoo Finance Australia

Two Years to Build or Pay 200% — Which US Pharma Stocks Win? - Sahm

AMPH5896384 Bond Profile — Key Metrics - TradingView

AMPH5896384 Bond Coupon Profile — Rate & Payments - TradingView

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat

Quantedge Capital Pte Ltd Sells 78,200 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

US3209RAB9 Bond Coupon Profile — Rate & Payments - TradingView

US3209RAB9 Bond Profile — Key Metrics - TradingView

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook and Growth Potential with 12% Upside - DirectorsTalk Interviews

Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal - ChartMill

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat

ALKS

$49.06

0.79%

RDY

$12.27

1.21%

ELAN

$23.67

5.15%

NBIX

$152.72

1.26%

VTRS

$16.23

1.18%

UTHR

$499.73

0.31%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters